Agilemed Investments Private Limited has pledged 62,51,066 equity shares of Medplus Health Services , representing 5.20% of the company’s total voting capital. The disclosure was made on August 21, 2026, pursuant to Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The pledge was created in favor of Catalyst Trusteeship Limited, acting in its capacity as Debenture Trustee for the benefit of debenture holders. This encumbrance does not involve a change in beneficial ownership but restricts the disposal rights of the pledged shares until the underlying obligations are met.

Pledge Details

The total encumbrance comprises three distinct pledge events executed over recent months. The breakdown of the shareholding encumbrance is detailed below.

The latest tranche, Encumbrance III, involved the pledge of 5,00,000 shares on August 19, 2026. Prior to this, Agilemed had already pledged 48,51,066 shares in December 2025 and an additional 9,00,000 shares in July 2026.

Capital Structure Impact

The total equity share capital of Medplus Health Services remains unchanged at 1,20,137,061 shares following these transactions. The total diluted share/voting capital stands at 1,20,237,751 shares. The acquirer, Catalyst Trusteeship Limited, holds no direct voting rights or other instruments convertible into equity shares; its holding consists solely of the encumbered shares described above.

What the Numbers Show

The progressive nature of the pledges indicates a staged approach to securing debt obligations. The initial large block of 48,51,066 shares pledged in December 2025 constitutes approximately 77.6% of the total currently encumbered stake. The subsequent smaller tranches in July and August 2026 suggest incremental financing needs or refinancing activities rather than a single bulk collateralization event. Investors should monitor future disclosures for any changes in the pledge status or additional encumbrances.

Medplus Health Services Limited held its 20th Annual General Meeting (AGM) on August 17, 2026, to transact ordinary and special business items. The meeting was conducted via Video Conferencing (VC) / Other Audio Visual Means (OAVM) in compliance with Ministry of Corporate Affairs (MCA) and Securities Exchange Board of India (SEBI) regulations.

Shareholders approved the adoption of the audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026. Statutory auditors B S R and Co and secretarial auditors R & A Associates issued unqualified opinions on the financial statements and matters bearing material impact on the company’s functioning.

Key Resolutions Passed

The AGM addressed several critical governance and operational resolutions:

• Financial Approval: Adoption of audited financial statements for FY26 along with reports from the Board of Directors and Auditors.
• Director Re-appointments: Dr. Cherukupalli Bhaskar Reddy was re-appointed as Whole Time Director after retiring by rotation. Gangadi Madhukar Reddy was re-appointed as Managing Director & CEO.
• Independent Director Appointments: Mr. Mohan Krishna Reddy and Mr. Ajit Pandurang Rangnekar were appointed as Independent Directors.
• Cost Auditor Ratification: Remuneration for M/s. M P R & Associates as Cost Auditors for FY27 was ratified.

Meeting Proceedings

Gangadi Madhukar Reddy, Chairman & Managing Director and CEO, chaired the proceedings which commenced at 3:30 pm and concluded at 4:47 pm. A total of 134 members attended the virtual meeting. The quorum was present at the start, enabling the transaction of all agenda items.

Ms. Rashida Adenwala of R & A Associates served as the Scrutinizer for the voting process. Remote e-voting was open from August 14, 2026, to August 16, 2026. Members present who had not voted remotely could cast votes via Insta Poll during the meeting. The consolidated voting results will be submitted to stock exchanges within prescribed timelines.